Single-use Bioreactors Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Global Single-use Bioreactors Market is segmented By Product (Single-use Bioreactors System, Single-use Media Bag, Single-use Filtration Assemblies, Others) By Type (Bubble Column Single-use Bioreactors, Stirred Tank Single-use Bioreactors, Wave Induced Single-use Bioreactors) By Molecule Type (Monoclonal Antibodies (MABs), Vaccine, Stem Cells, Gene–Modified Cells, Other Molecules) By Cell Type (Mammalian Cells, Bacteria Cells, Yeast Cells, Other Cells) By Application (Research and Development, Process Development, Bio production) By End User (Academic & Research Institutes, CROs and CMOs, Pharmaceutical & Biotechnology Companies, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Report Overview

The Global Single-use Bioreactors market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

A single-use bioreactor is a type of bioreactor that uses a disposable bag instead of a culture vessel. This technology allows manufacturers to use disposable bags in the manufacturing process, which was previously only possible with stainless steel equipment. The use of single-use bags helps to minimize the risk of cross contamination and improves the safety of the biological and process. These bioreactors are particularly well-suited for biopharmaceutical products.

Single-use Bioreactors Market Scope

For more details on this report – Request for Sample

Single-use Bioreactors Market Dynamics

Increasing Advanced Products Introductions

The increasing advanced product launches in the market are expected to boost the global market during the forecast period. For instance, in March 2022, Dundee-based Cellexus International launched a single-use airlift bioreactor that permits researchers to grow fragile cell cultures for their investigation more swiftly and cost effectively. 

Rather of utilizing intenser mixing procedures, the Cell Maker single-use airlift bioreactors create bubbles that ooze via the blend, yielding a gentle mixing action for even the considerably delicate cell cultures. Moreover, in March 2020, Sartorius Stedim Biotech launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform developed to produce biopharmaceutical development and production quickly, more straightforward and securer.

Furthermore, the technological advancements, rise in research activities, increasing investments, growing cases of chronic and heridaitery conditions and increaseing awareness are among the other additional factors boosting the global market growth during the forecast period.

High Frequent Costs

The high frequent costs are anticipated to hamper growth of the single-use bioreactor market. For instance, periodic costs for single-use bioreactors has been encountered to be high, the expense concerned with the waste management of considerable amounts of disposables is also elevated. SUBs cause more additional disposal costs corresponded to reusable units, which already has high upfront costs in terms of installation and upkeep. Furthermore, the lack of skilled professionals and parameter regulation associated concerns are among the additional factors slowing the global market growth during the forecast period.

Single-use Bioreactors Market Segment Analysis

The global single-use bioreactors market is segmented based on product, type, molecule type, cell type, application, end user and region.

Single-use Bioreactors System Product Segment are Expected to Dominate Market

Owing to the increasing market developments such as product launches and investments in the single-use bioreactors system product segment, the segment is expected to dominate the global market during the forecast period. For instance, in January 2023, PBS Biotech, an innovative, single-use bioreactor system manufacturer and process development Single-use Filtration Assemblies provider, secured a $22 million financing led by Avego Management, LLC with further investment from existing investor BroadOak Capital Partners.

This investment is intended to be utilized for enhancing the corporation's development portfolio, extending its process development Single-use Filtration Assemblies capability, and improving customer assistance to global cell therapy clients. Moreover, in January 2019, Sartorius Stedim Biotech (SSB), a top international provider for the biopharmaceutical industry launched the BIOSTAT RM TX single-use bioreactor, a new wave mixed system designed especially for closed, automated expansion of uniform quality cell products like ex vivo cellular immunotherapies.

Single-use Bioreactors Market Geographical Share

North America is Expected to Dominate the Global Market

Owing to the presence of key market players holding large share of the global market by performing distinct market tactics in North America, the region is expected to dominate the global market during the forecast period. For instance, in in November 2022, Danaher Corporation's United States-based subsidiary, Cytiva invested about USD 8 million to extend its Fast Trak center in Shanghai, China. 

The Single-use Technologies (SUT) Center of Excellence in Asia presents unique development R&D trials and verification intending to promote the industry’s application of SUT throughout the province. Moreover, in August 2022, Thermo Fisher Scientific, a United States-based multinational market leader inaugurated its most extensive single-use technology manufacturing location in Greater Nashville with an investment of USD 105 million to satisfy the increasing demand for the bioprocessing materials required to create vaccines and breakthrough treatments for cancer and other disorders.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the global demand for bioreactors has increased due to their widespread usage in cell culture-based viral vaccine production. This has presented significant growth opportunities for players in the single-use bioreactor market. For instance, ABEC delivered six 4,000L CSR bioreactors to Serum Institute of India in September 2020 to quicken the production of Novavax’ COVID-19 vaccine nominee, NVX CoV2373. In addition, Serum Institute leveraged ABEC’s single-use technology to boost the supply of NVX CoV2373 to low- and middle-income nations.

Key Developments

• In November 2022, Sartorius GA, planned to invested in expanding its processes by setting new R&D laboratories and digitalizing & automating equipment, with other courses. 
• In December 2022, Merck completed the acquisition of Erbi Biosystems, a Massachusetts-based corporation that develops a 2ml micro bioreactor platform, Breez, intended to strengthen Merck’s upstream portfolio in the therapeutic protein segment.
• In October 2021, Agilitech, a United States-based corporation that delivers simultaneous control of up to two single-use bioreactors from 30 L up to 2000 L launched the Agilitech bioreactor controller.

Single-use Bioreactors Market Major Players

The major global players in the market include ABEC, Thermo Fisher Scientific, Inc., Sartorius AG, Pall Corporation, Celltainer, Distek, Inc., Merck KGaA, PBS Biotech, Inc., CYTIVA and Eppendorf SE.

Why Purchase the Report?

• To visualize the global single-use bioreactors market segmentation based on product, type, molecule type, cell type, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of single-use bioreactors market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global single-use bioreactors market report would provide approximately 69 tables, 69 figures and 184 pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies